Small volume - Large benefit?

Anaesthesist

Volumn 50, Issue 6, 2001, Pages 442-449

  Kreimeier, U ^a   Peter, K ^a   Messmer K ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; FLUID THERAPY; HEMODYNAMICS; HEMORRHAGIC SHOCK; HYPEROSMOLARITY; HYPOVOLEMIC SHOCK; RESUSCITATION; BLOOD VOLUME; COLLOID; DRUG EFFECT; HUMAN; HYPOVOLEMIA; REVIEW;

HETASTARCH; PLASMA SUBSTITUTE;

BLOOD VOLUME; COLLOIDS; HETASTARCH; HUMANS; HYPOVOLEMIA; PLASMA SUBSTITUTES; RESUSCITATION;

EID: 0034743513     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010100143     Document Type: Conference Paper

References (76)

1. Effects of hypertonic-hyperoncotic infusion on the human atrial natriuretic factor in a standardized clinical trial
2. Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms
3. Epidemiology of trauma: The civilian perspective
4. Hypertone lösungen zur behandlung des intrakraniellen drucks
5. Use of hypertonic saline/dextran versus lactated Ringer's solution as a resuscitation fluid after uncontrolled aortic hemorrhage in anesthetized swine
6. Kolloidhaltige hypertone Lösungen in der Kardiochirurgie
7. Volume loading with hypertonic saline solution: Endocrinologic and circulatory responses
8. The effects of resuscitation with hypertonic vs. hypotonic vs. colloid on wound and urine fluid and electrolyte losses in severely burned children
9. Osmolar and electrolyte changes in hemorrhagic shock. Hypertonic solutions in the prevention of tissue damage
10. The role of secondary brain injury in determining outcome from severe head injury
11. Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank
12. Hyperosmotic-hyperoncotic solutions during abdominal aortic aneurysm (AAA) resection
13. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections
14. A review of the efficacy and safety of 7.5% NaCl/6% Dextran 70 in experimental animals and in humans
15. Dextran metabolism following infusion of 7.5% NaCl/6% Dextran-70 to euvolemic and hemorrhaged rabbits
16. Guidelines for resuscitation and transfer of patients with serious head injury
17. Circulatory shock and physiology of its treatment
18. Decrease of intracranial pressure following a combination of hypertonic saline and hydroxyethyl starch
19. Effects of hypertonic saline on hemodynamic and oxygen transport-related variables in critically ill patients
20. Reduction of therapy-resistant intracranial pressure by application of hypertonic saline (7.5%)
21. Hypertonic saline in stabilized hyperdynamic sepsis
22. Hypertonic/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension
23. The effects of 7.5% NaCl/6% Dextran 70 on coagulation and platelet aggregation in humans
24. 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients
25. Hypertonic saline solutions for postoperative plasma volume expansion after mitral valve repair
26. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates
27. Prognosis in acute organ-system failure
28. Small-volume resuscitation with hypertonic saline dextran solution
29. Hypertonic saline dextran: Efficacy and regulatory approval
30. Effect of injured vessel size on bleeding following hypertonic saline infusion in uncontrolled hemorrhagic shock in anesthetized rats
31. "Scoop and run" or stabilize hemorrhagic shock with normal saline or small-volume hypertonic saline?
32. The combined effect of small volume hypertonic saline and normal saline solutions in uncontrolled hemorrhagic shock
33. Small-volume resuscitation
34. Hypovolaemic shock
35. Prähospitale flüssigkeitstherapie
36. Volumen-therapie bei hypovolämie und schock
37. Hyperosmotic saline dextran for resuscitation from traumatic-hemorrhagic hypotension: Effect on regional blood flow
38. Small-volume resuscitation beim hypovolämischen schock: Konzeption, experimentelle und klinische ergebnisse - Eine standortbestimmung
39. Permissive hypotension
40. Dextran for traumatic shock patients in spite of possible anaphylactic reactions?
41. Safety of dextran in relation to other colloids - Ten years experience with hapten inhibition
42. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension - The U.S.A. multicenter trial
43. Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage
44. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion
45. Microcirculatory therapy in shock
46. Die Wirkung hypertoner Lösungen bei Ratten im irreversiblen Schock
47. Effectiveness of Dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome
48. The role of concentrated sodium solutions in the resuscitation of patients with severe burns
49. Effects of a highly concentrated hypertonic saline-dextran volume expander on cardiopulmonary function in anesthetized normovolemic horses
50. Small-volume resuscitation with hypertonic saline (2,400 mOsm/liter) during hemorrhagic shock
51. Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran
52. Hyperton-hyperon-kotischer volumenersatz (7,S% NaCl/10% hydroxyethylstärke 200.000/0.5) bei patienten mit koronararterienstenosen
53. Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline - Influence of a subdural mass
54. Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock
55. Hemodynamic effects of hypertonic hydroxy-ethyl starch 6% solution and isotonic hydroxy-ethyl starch 6% solution after declamping during abdominal aortic aneurysm repair
56. Hypertonic saline alters plasma clotting times and platelet aggregation
57. Safety and efficacy of hypertonic saline dextran in pediatric patients submitted to cardiac surgery with cardiopulmonary bypass
58. Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock
59. Treatment of hemorrhagic hypotension with hypertonic/hyperoncotic solutions: Effects on regional cerebral blood flow and brain surface oxygen tension
60. Hypertonic sodium lactate versus lactated Ringer's solution for intravenous fluid therapy in operations on the abdominal aorta
61. Epidemiology and pathology of traumatic death occurring at a level I trauma center in a regionalized system: The importance of secondary brain injury
62. Crystalloid and colloid fluid therapy in resuscitation and subsequent ICU management
63. Acute and subacute toxicity of 7.S% hypertonic saline/6% dextran70 (HSD)in dogs 1. Serum immunoglobulin and complement responses
64. Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions
65. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride - The effect of added dextran 70
66. Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock
67. 7.5% Sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport
68. Efficacy of hypertonic saline dextran (HSD) in patients with traumatic hypotension: Meta-analysis of individual patient data
69. Effect of dehydration on cardiovascular responses and electrolytes after hypertonic saline/dextran treatment for moderate hemorrhage
70. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension
71. Hypertone, hyperonkotische hydroxyäthylstärke-lösung zur senkung des intrakraniellen druckes
72. Weight gain after coronary bypass operations
73. Cardiac function in small volume resuscitation
74. The diagnosis and initial management of head injury
75. Treatment of resistant intracranial hypertension with hypertonic saline